Therapeutics: Major histocompatibility complex class I A 2 (HLA-A2)

Transplant

INDICATION: Graft-versus-host disease (GvHD)

Cell culture and mouse studies suggest Tregs engineered to

Read the full 128 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE